Lu Chen

4.7k total citations · 1 hit paper
140 papers, 3.4k citations indexed

About

Lu Chen is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Lu Chen has authored 140 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Molecular Biology, 37 papers in Oncology and 33 papers in Cancer Research. Recurrent topics in Lu Chen's work include MicroRNA in disease regulation (14 papers), Cancer-related molecular mechanisms research (14 papers) and RNA modifications and cancer (13 papers). Lu Chen is often cited by papers focused on MicroRNA in disease regulation (14 papers), Cancer-related molecular mechanisms research (14 papers) and RNA modifications and cancer (13 papers). Lu Chen collaborates with scholars based in China, United States and United Kingdom. Lu Chen's co-authors include Stanley J. Wiegand, Patrìcia A. D'Amore, M. Reza Dana, Claus Cursiefen, Czeslaw Radziejewski, J. Wayne Streilein, David G. Jackson, Jingtai Cao, Christopher I. Li and Xiang Yang Chen and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Journal of Neuroscience.

In The Last Decade

Lu Chen

128 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment

2004 866 citations Lu Chen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lu Chen China	30	1.2k	1.0k	507	443	345	140	3.4k
Jiang Chang China	37	1.9k 1.5×	876 0.9×	744 1.5×	252 0.6×	327 0.9×	134	8.5k
Kiyoko Kato Japan	36	2.3k 1.9×	914 0.9×	546 1.1×	440 1.0×	387 1.1×	304	5.4k
Ting Fu China	31	1.4k 1.2×	503 0.5×	487 1.0×	319 0.7×	289 0.8×	152	3.6k
Huiping Li China	30	1.3k 1.0×	1.2k 1.2×	715 1.4×	228 0.5×	140 0.4×	250	3.7k
Li Yan China	34	1.3k 1.1×	366 0.4×	391 0.8×	378 0.9×	230 0.7×	269	4.8k
Jingjing Wu China	32	944 0.8×	642 0.6×	313 0.6×	444 1.0×	611 1.8×	207	3.6k
Anne Gompel France	47	1.2k 1.0×	1.3k 1.3×	469 0.9×	477 1.1×	970 2.8×	189	6.5k
Lars Sävendahl Sweden	40	1.7k 1.4×	506 0.5×	259 0.5×	249 0.6×	206 0.6×	154	4.9k
TP Ng Hong Kong	44	1.6k 1.3×	777 0.8×	716 1.4×	796 1.8×	262 0.8×	150	4.9k
Yu Yang China	31	1.0k 0.9×	634 0.6×	401 0.8×	661 1.5×	133 0.4×	113	3.5k

Countries citing papers authored by Lu Chen

Since Specialization

Citations

This map shows the geographic impact of Lu Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Chen more than expected).

Fields of papers citing papers by Lu Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lu Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Chen. The network helps show where Lu Chen may publish in the future.

Co-authorship network of co-authors of Lu Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Lu Chen. A scholar is included among the top collaborators of Lu Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lu Chen. Lu Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Yawei, Lu Chen, Heng Jia, et al.. (2025). Targeting HCG18 counteracts ferroptosis resistance via blocking the miR-30a-5p/RRM2/GSS pathway in hepatocellular carcinoma. International Journal of Biological Sciences. 21(6). 2550–2567. 2 indexed citations

Zhu, Wei, et al.. (2025). Construction of a lung adenocarcinoma prognostic model based on KEAP1/NRF2/HO‑1 mutation‑mediated upregulated genes and bioinformatic analysis. Oncology Letters. 29(3). 155–155.

Zeng, Chao, et al.. (2025). Quality Assessment of Chinese TikTok as a Source of Information About Esophageal Cancer. Journal of Cancer Education. 41(1). 101–107.

Chen, Lu, et al.. (2025). Nanodrug Delivery Systems for Direct Clearance or Neutralization of LPS. International Journal of Nanomedicine. Volume 20. 8653–8673. 1 indexed citations

Shouse, Geoffrey, Lu Chen, D. Lynne Smith, et al.. (2025). Copanlisib in combination with venetoclax in patients with relapsed/refractory mantle cell lymphoma. Leukemia & lymphoma. 66(14). 2790–2793.

Wang, Xue, Lu Chen, Jun Lv, et al.. (2024). Diabetes and chronic kidney disease in Chinese adults: a population-based cohort study. BMJ Open Diabetes Research & Care. 12(1). e003721–e003721. 2 indexed citations

Ke, Yilang, et al.. (2024). Loss of Endothelial Annexin A1 Aggravates Inflammation‐Induched Vascular Aging. Advanced Science. 11(15). e2307040–e2307040. 14 indexed citations

Torka, Pallawi, Lu Chen, Xiaoguang Wang, et al.. (2023). Pevonedistat, a Nedd8-activating enzyme inhibitor, in combination with ibrutinib in patients with relapsed/refractory B-cell non-Hodgkin lymphoma. Blood Cancer Journal. 13(1). 9–9. 11 indexed citations

Chen, Lu, Wujiang Gao, Chunli Sha, et al.. (2023). A methylation- and immune-related lncRNA signature to predict ovarian cancer outcome and uncover mechanisms of chemoresistance. Journal of Ovarian Research. 16(1). 186–186. 12 indexed citations

10.

Zhang, Jinnan, Haiqing Zhao, Lu Chen, et al.. (2023). Multifaceted roles of WRKY transcription factors in abiotic stress and flavonoid biosynthesis. Frontiers in Plant Science. 14. 1303667–1303667. 26 indexed citations

11.

Xie, Jiahe, Mingyuan He, Lu Chen, et al.. (2023). Pregnancy-induced physiological hypertrophic preconditioning attenuates pathological myocardial hypertrophy by activation of FoxO3a. Cellular and Molecular Life Sciences. 80(9). 267–267. 2 indexed citations

12.

Chen, Liwei, Yuchao He, Zhiqiang Han, et al.. (2023). The impact of decreased expression of SVEP1 on abnormal neovascularization and poor prognosis in patients with intrahepatic cholangiocarcinoma. Frontiers in Genetics. 13. 1127753–1127753. 3 indexed citations

13.

Chen, Lu, Chang‐Hui Ge, Xiuxue Feng, et al.. (2022). Identification of Combinations of Plasma lncRNAs and mRNAs as Potential Biomarkers for Precursor Lesions and Early Gastric Cancer. Journal of Oncology. 2022. 1–13. 4 indexed citations

14.

Zhang, Donghui, Fei Chen, Jiahui Wang, et al.. (2022). Pipiserpin, a Culex factor Xa inhibitor, affects female reproductive capacity and serves as a potential target for mosquito control. Pest Management Science. 78(8). 3433–3441.

15.

Ren, Shaohua, Guangtao Li, Fang Fěng, et al.. (2022). Predictive Value of Preoperative Serum AFP, CEA, and CA19-9 Levels in Patients with Single Small Hepatocellular Carcinoma: Retrospective Study. SHILAP Revista de lepidopterología. Volume 9. 799–810. 9 indexed citations

16.

Chen, Yajie, Ahmed Bilal Waqar, Kazutoshi Nishijima, et al.. (2020). Macrophage‐derived MMP‐9 enhances the progression of atherosclerotic lesions and vascular calcification in transgenic rabbits. Journal of Cellular and Molecular Medicine. 24(7). 4261–4274. 42 indexed citations

17.

Chen, Lu, et al.. (2020). Long Noncoding RNA NEAT1 Promotes the Progression of Breast Cancer by Regulating miR-138-5p/ ZFX Axis. Cancer Biotherapy and Radiopharmaceuticals. 37(8). 636–649. 13 indexed citations

18.

Chen, Lu, Jessica Chubak, Denise M. Boudreau, et al.. (2017). Diabetes Treatments and Risks of Adverse Breast Cancer Outcomes among Early-Stage Breast Cancer Patients: A SEER-Medicare Analysis. Cancer Research. 77(21). 6033–6041. 32 indexed citations

19.

Li, Zhi‐Hua, Lu Chen, Yanhua Wu, et al.. (2014). Effects of Mercury on Oxidative Stress and Gene Expression of Potential Biomarkers in Larvae of the Chinese Rare Minnow Gobiocypris Rarus. Archives of Environmental Contamination and Toxicology. 67(2). 245–251. 43 indexed citations

20.

Chen, Lu, Danyang Ren, Xiaohui Wang, et al.. (2013). Toll-like receptor 3 plays a role in myocardial infarction and ischemia/reperfusion injury. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1842(1). 22–31. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact